Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Sai Priya Anand; Jeremie Prevost; Manon Nayrac; Guillaume Beaudoin-Bussieres; Mehdi Benlarbi; Romain Gasser; Nathalie Brassard; Annemarie Laumaea; Shang Yu Gong; Catherine Bourassa; Elsa Brunet-Ratnasingham; Halima Medjahed; Gabrielle Gendron-Lepage; Guillaume Goyette; Laurie Gokool; Chantal Morrisseau; Philippe Begin; Valerie Martel-Laferriere; Cecile Tremblay; Jonathan Richard; Renee Bazin; Ralf Duerr; Daniel E Kaufmann; Andres Finzi.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-428097

Documentos relacionados

  1. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
  2. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
  3. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.
  4. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
  5. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
  6. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
  7. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.
  8. Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.
  9. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
  10. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.